Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo

This article was originally published in The Tan Sheet

Executive Summary

Private label manufacturer launching three new products featuring "ionic trace minerals" for "energy and vitality" in the first quarter of 2000. The Allegan, Mich.-based firm introduced the line at the Private Label Manufacturers Association's annual trade show in Chicago Nov. 14-16. The products are Bone Health, with magnesium, zinc and calcium; Multiple Vitamin, with Panax ginseng for "higher energy levels"; and Women's Multiple, with soy isoflavones and black cohosh "for menopausal support and bone health," according to promotional materials. The firm also is shipping two recently introduced soy products, available for private label or under the DailySource brand: Soy Formula and Calcium 600+Soy "for menopausal health," both of which contain Archer Daniels Midland's patented NovaSoy extract. Other new products include DailySource NutriEye with Lutein, which Perrigo describes as an "advanced dietary and antioxidant supplement for the eyes"

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel